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Systemic lupus erythematosus (SLE) is a chronic, complex, and systemic human autoimmune disease, with both an
environmental component and a heritable predisposition. Clinical studies, reinforced by epidemiology and genetics,
show impressive variation in disease severity, expression, prevalence, and incidence by ethnicity and sex. To identify
the novel SLE susceptibility loci, we performed a genomewide scan with 318 markers on 37 multiplex Hispanic
families, using a nonparametric penetrance-independent affected-only allele-sharing method. Three chromosomal
regions (12q24, 16p13, and 16q12-21) exceeded our predetermined threshold ( ; nominal ) for furtherZ 1 2.32 P ! .01lr
evaluation. Suspected linkages at 12q24, 16p13, and 16q12-21 were tested in an independent data set consisting of
92 European American (EA-1) and 55 African American (AA) families. The linkage at 12q24 was replicated
in EA-1 ( ; ) but not in AA ( ; ). Although neither the 16p13 nor the 16q12-Z p 3.06 Pp .001 Z p 0.37 Pp .35lr lr
21 was confirmed in EA-1 or AA, the suggestive linkage ( ; ) at 16q12-21 is sufficient to confirmZ p 3.06 Pp .001lr
the significant linkage, reported elsewhere, at this location. The evidence for linkage at 12q24 in the 129 combined
(Hispanic and EA-1) families exceeded the threshold for genomewide significance ( ; ;56Z p 4.39 Pp 5.7# 10lr
nonparametric ). Parametric linkage analyses suggested a low-penetrance, dominant model (LODp 4.19 LODp
). To confirm the linkage effect at 12q24, we performed linkage analysis in another set of 82 independent European3.72
American families (EA-2). The evidence for linkage was confirmed ( ; ). Therefore, our resultsZ p 2.11 Pp .017lr
have detected, established, and confirmed the existence of a novel SLE susceptibility locus at 12q24 (designated
“SLEB4”) that may cause lupus, especially in Hispanic and European American families.
Introduction
Systemic lupus erythematosus (SLE [MIM 152700]) is a
complex disease in which immune responses are directed
against a multitude of self-antigens. SLE in humans mani-
fests a diverse array of clinical symptoms, variably in-
volving multiple organ systems. The pathogenesis is re-
lated to dysregulation of self-reactive B cells, which leads
to immune complex activation and complement con-
sumption. The production of autoantibodies against nu-
clear components is the unifying characteristic of SLE.
Antinuclear antibody (ANA) testing is very sensitive for
the disease, although not specific, since ANA antibodies
are sporadically detected in 5% of the female popu-
lation of age 140 years. On the other hand, antibodies
to double-stranded DNA, ribosomal P protein, or Sm
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protein are very specific for SLE but are not particularly
sensitive.
The overall estimated prevalence of SLE in the United
States is 12–64 cases per 100,000 individuals (Hochberg
1997a; Lawrence et al. 1998). Significant sex differences
are observed in prevalence (female:malep 9:1), age at
onset, premorbid conditions, clinical expression, course
of illness, response to treatment, and morbid risk. In
addition, there are important racial differences in preva-
lence and disease manifestations. For example, a two-
to fourfold higher incidence of SLE is observed in the
African American (AA), as compared with European
American (EA), population (Petri 1998).
The familial aggregation of SLE suggests an under-
lying genetic susceptibility; but environmental, stochas-
tic, or epigenetic factors must be important, since even
MZ twins are not usually concordant for disease. Sub-
stantial evidence has shown that SLE clusters in families,
with 7%–12% increased risk among the first- or second-
degree relatives of a proband. There is an increased
concordance rate in MZ twins (15%–69%), as opposed
to DZ twins (2%–5%) (Deapen et al. 1992). The rela-
tive risk ratio for the siblings of an affected proband (ls)
varies from 20 to 40 (Wandstrat and Wakeland 2001).
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Table 1
Selected Clinical and Demographic Features of the SLE-Affected Individuals
Population
No.
of Families
No. of SLE-Affected
Individuals
Sex
(male:female)
No. of SLE-Affected
Individuals per Family
Age at Onset
 SD
(years)
Age at Enrollment
 SD
(years)
Hispanic 37 91 85:11 2.46 32.012.3 38.612.5
AA 55 128 121:7 2.33 34.410.7 40.211.0
EA-1 92 214 197:17 2.33 35.013.5 42.013.5
EA-2 82 179 162:17 2.18 36.013.7 44.313.9
Moreover, the complex pattern of inheritance of SLE
suggests multigenic inheritance, which requires inter-
action of various combinations of contributing genes at
multiple loci in individual patients.
For disorders, such as SLE, that have a poorly known
biochemical basis, identification of the genes is a pre-
requisite to understanding its biological basis. There-
fore, identification of the genes contributing to sus-
ceptibility in SLE will elucidate the development and
pathogenesis of the disease and may lead to novel thera-
peutic interventions. In addition, genetic screening could
be used to identify individuals who are at risk so that
they can take advantage of early diagnosis and treatment.
Here, we report results of a genomewide search for
candidate regions for SLE susceptibility. First, we present
the results of an independent first-stage genome scan on
a set of 37 Hispanic families multiplex (at least two af-
fected relatives per family) for SLE, and we identify three
potential candidate regions for SLE susceptibility. Sec-
ond, two independent samples consisting of 55 AA and
92 EA (EA-1) families are used to replicate the results.
Combined study of the Hispanic and EA-1 families has
established the significant evidence of linkage at 12q24.
Third, we present a plausible genetic model for SLE at
12q24. Fourth, we have replicated the evidence for link-
age at 12q24 in another set of 82 independent EA families
(EA-2).
Material and Methods
Family Ascertainment
Families with SLE were recruited from all regions of
the United States. Multiplex families were ascertained
for linkage study. All the patients with SLE met the 1997
revised criteria for classification of SLE (Hochberg 1997b;
Tan et al. 1982). All patient material was gathered, after
receiving informed consent from participants, under pro-
tocols approved by the Oklahoma Medical Research
Foundation and University of Oklahoma Health Sciences
Center institutional review boards. Each potential par-
ticipant with SLE was interviewed and asked to complete
an extensive questionnaire that included demographic
variables. All available medical records of SLE-affected
family members were reviewed to confirm the diagnosis.
In some cases, the participant’s physician was also inter-
viewed. Family members without SLE completed a less
extensive questionnaire to screen for SLE and other auto-
immune diseases. Clinical manifestations were defined
as either “present” or “absent” on the basis of the defini-
tions in the SLE classification criteria.
Currently, the pedigree collection consists of three self-
identified ethnic groups: EA, AA, and Hispanic. The same
recruitment procedure was adopted for all families with
SLE. From our collection (Lupus Multiplex Registry and
Repository), we have ascertained 37 Hispanic families
multiplex for SLE. On the basis of the demographic re-
cords of the Hispanic families, we found that the ma-
jority (76%) are Mexican American; 16% are Puerto
Rican. Two independent replication samples consisted
of 92 EA families (EA-1) and 55 AA families; another
independent replication sample consisting of 82 EA fam-
ilies (EA-2) (table 1) was used to cross-validate the initial
linkage results. Whereas all the families from the EA-1
and AA populations have been studied before in SLE
genome scans (Moser et al. 1998; Gray-McGuire et al.
2000), the EA-2 families are reported here for the first
time. All the linkage analyses were done using the fami-
lies multiplex for SLE.
Genotyping and Error Checking
Genomic DNA was isolated, by use of standard meth-
ods, from peripheral blood cells, buccal cell swabs, mouth
wash specimens, or EBV-transformed cell lines. Detailed
methods for the genotyping of families had been described
elsewhere (Moser et al. 1998; Gray-McGuire et al. 2000).
A total of 318 microsatellite markers, with an average
marker spacing of 11 cM (range 2–22 cM) and a hetero-
zygosity of 76% (with a range of 56%–94%), was typed.
We used the genetic map and intermarker distances from
the Marshfield map. Positions of markers not in the
Marshfield map were set by interpolation on the basis of
physical distances. Prior to linkage analysis, all family re-
lationships were confirmed using RELTEST (Olson 1999).
Statistical Methods for Linkage Analysis
In complex diseases, such as SLE, the parameters of the
disease model (mode of inheritance, disease-allele fre-
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quency, and penetrances of genotypes) are uncertain. We
therefore assessed the evidence for linkage in the initial
genome scan with a nonparametric, penetrance-indepen-
dent, affected-only, allele-sharing method (Kong and Cox
1997). The linkage analysis was performed using the pro-
gram ALLEGRO (Gudbjartsson et al. 2000), which is a
modification of the GENEHUNTER (Kruglyak et al.
1996) package.
The nonparametric LOD score was obtained, in part,
by maximizing the likelihood with respect to a scalar
parameter, d, that measures the amount of excess iden-
tical-by-descent sharing among affected relatives (with
, corresponding to the null hypothesis of no link-dp 0
age [Kong and Cox 1997; Gudbjartsson et al. 2000]).
We used the Spairs scoring function (Whittemore and Hal-
pern 1994; Kruglyak et al. 1996) and the exponential
allele-sharing model to generate the relevant statistic (Zlr).
Among the allele-sharing approaches, this scoring func-
tion has been found to perform well for a variety of un-
derlying disease models (McPeek 1999). Finally, the P
value was computed on the basis of large-sample theory;
the distribution of approxi-Z p [2# log (10)LOD]lr e
mates a standard normal random variable under the null
hypothesis (Kong and Cox 1997; Gudbjartsson et al.
2000). Individual family scores were combined to obtain
an overall score, by use of a weighting scheme that, on
the log scale, is halfway between weighting the families
equally (Kruglyak et al. 1996) and weighting the affected
relative pairs equally. This scheme gives weights similar
to those proposed by Weeks and Lange (1988), as an
extension of the scheme that was originally designed for
sibships (Hodge 1984).
Upon establishing a linkage by exceeding the thresh-
old for genomewide significance using an allele-sharing
method, we fitted a range of parametric models to the
data, in an effort to explain the underlying genetic model.
We estimated the race-specific marker-allele frequencies
from family founders, using FASTLINK (Cottingham et
al. 1993). Parametric linkage analysis assuming linkage
homogeneity (LOD) and linkage heterogeneity (HLOD)
scores were obtained using both GENEHUNTER-PLUS
(Kruglyak et al. 1996) and ALLEGRO (Gudbjartsson et
al. 2000). Significance of a LOD score was determined
by , with 1 df. Since HLOD follows a2x p 4.6# LOD
complex statistical distribution, significance for the ob-
served HLOD was first converted to a x2, where 2x p
. P value (P1) was then derived for x
2 by4.6#HLOD
use of the x2 distribution, with 1 df. The P value for the
HLOD score was then (Far-0.5# [1 (1 P )(1 P )]1 1
away 1993).
We also performed the simulations to determine the
proper significance of linkage results for the confirma-
tory group. Empirical P values for the complete data set
were obtained by simulation of 10,000 sets of three mark-
ers (representing EA-2) not linked to a susceptibility locus
generated by the ALLEGRO program (Gudbjartsson et
al. 2000). Pedigree structures, phenotypic classifications,
and genetic models were the same as those used in the
actual analysis for EA-2, but marker information was
generated without regard to the affection status. The best
Zlr score over each simulated data set was extracted and
compiled into a single distribution. Zlr from the real analy-
sis was compared with this distribution to determine how
frequently this result would be observed by chance in an
unlinked data set. This was reported as the empirical P
value.
Results
Clinical Characteristics of the Patients
The comparison of major family and demographic
characteristics shows that, overall, the four groups are
similar (table 1). We assessed the significance of the quan-
titative variables, using one-way ANOVA and post hoc
Tukey test for multiple pairwise comparisons between
groups. The mean age at onset for affected individuals
did not vary significantly among the four groups (Fp
; ). To see whether nonindependence or re-1.95 Pp .12
latedness among the patients is a problem, given the na-
ture of the family data, we randomly selected one patient
with SLE per family and recalculated ANOVA. We found
similar results ( ; ). The post hoc pair-Fp 1.19 Pp .31
wise comparison between groups also resulted in a similar
conclusion.
Genome Scan for SLE Susceptibility
Initially, we performed a genome scan for SLE linkage
on 37 Hispanic families on the basis of multipoint non-
parametric linkage analysis (fig. 1). Seven different ge-
nomic locations yielded the Zlr value 11.65 ( )P ! .05
(table 2). Among them, three genomic regions produced
evidence of linkage exceeding our predetermined thresh-
old ( ; ) for further evaluation. The peakZ 1 2.32 P ! .01lr
at 12q24 ( ; ) was found onZ p 3.31 Pp .00047lr
D12S395 at 130 cM, the peak at 16p13 was on
D16S764 at 18 cM ( ; ), and theZ p 2.62 Pp .004lr
peak at 16q12-21 ( ; ) was betweenZ p 3.06 Pp .001lr
marker D16S3253 and D16S1624 at 66.8 cM (table 2).
The last column of table 2 provides information about
the genomic locations reported by other groups.
Linkage at 12q24
In an effort to reevaluate the validity of our initial re-
sults at 12q24, 16p13, and 16q12-21, we tested linkage
on an independent data set of 147 families with SLE. This
data set consisted of 92 EA families (EA-1) and 55 AA
families. Since our a priori hypothesis of linkage to SLE
at 12q24, 16p13, and 16q12-21 was fixed, we genotyped
only three or four markers (peak marker or markers and
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Table 2
Markers Yielding Multipoint ( ) from the Hispanic Genome ScanZ 1 1.65 P ! .05lr
CYTOGENETIC
LOCATION
LINKAGE PEAK
Zlr P PUBLISHED REPORTS FOR LINKAGEMarker(s)
Position
(cM)
1p36 D1S552 14.8 2.11 .017 Gaffney et al. 2000; Johanneson et al. 2002
3p14 D3S2406 108.0 1.87 .031
9q34 D9S2157 113.2 1.83 .034
12q24 D12S395 130.3 3.31 .00047
16p13 D16S764 18.0 2.62 .004
16q12-21 D16S3253-D16S2624 66.8 3.06 .001 Shai et al. 1999; Gaffney et al. 2000; Tsao et al. 2002
20p13 D20S103 1.8 1.80 .036 Gaffney et al. 1998
the two flanking markers [one from either side]) used in
the genome scan. The markers and intermarker distances
(cM) used for linkage analysis at three genomic locations
are as follows: 12q24 (D12S2070-13.9-D12S395-12.7-
D12S2070), 16p13 (D16S748-7-D16S764-14-D16S403),
and 16q12-21 (D16S-753-14-D16S3253-16-S2624-13-
D16S516). On the basis of multipoint linkage analysis,
the initial linkage signal at 12q24 was replicated in EA-
1 ( ; ), but virtually no evidence forZ p 3.06 Pp .0011lr
linkage was found in the AA families ( ;Z p 0.37 Pplr
). The corresponding nonparametric LOD for EA-1.35
and AA were 2.03 and 0.03, respectively. However, on
the basis of multipoint linkage analysis, the initial linkage
signal at 16p13 was not replicated either in EA-1 families
( ; ) or in AA families ( ;Z p 0.38 Pp .35 Z p 0.59lr lr
). Nonsignificant results were also observed forPp .72
linkage at 16q12-21 in EA-1 ( ; ) andZ p 0.62 Pp .27lr
in AA families ( ; ).Z p 0.69 Pp .24lr
We then combined our Hispanic families with EA-1 (a
total of 129 families) and reanalyzed the linkage effect at
12q24 in the combined families. The evidence of linkage
( ; ) at 12q24 exceeded the6Z p 4.39 Pp 5.7# 10lr
threshold for genomewide significance recommended in
Lander and Kruglyak’s (1995) guidelines for interpreting
linkage results for complex diseases. The maximum evi-
dence of linkage (peak LOD score) was found at D12S395
at 130.3 cM (fig. 2). The corresponding nonparametric
LOD score was 4.19 at this marker. To our knowledge,
significant evidence of any SLE susceptibility locus at
12q24 has not been described elsewhere. We designated
this novel SLE susceptibility locus “SLEB4.”
Parametric Model for Linkage at 12q24
Hodge and Elston (1994) showed that maximization
of LOD scores over a range of genetic models (i.e., cal-
culation of maximized LOD scores) is a valid procedure
that does not require adjustment of significance levels or
a correction for ascertainment. Further, they showed that
evaluation for linkage and determination of the most
likely genetic model for a data set may proceed simul-
taneously, provided there is a linked marker. Accordingly,
after establishing the SLE linkage at 12q24 by the non-
parametric allele-sharing method, we attempted to under-
stand the genetic model (mode of inheritance) of this sus-
ceptibility locus by fitting a range of single-locus domi-
nant, recessive, and additive models to the data (table 3).
The results of multipoint parametric linkage, under the
assumption of genetic homogeneity and heterogeneity for
the best-fitted genetic model, are shown in table 4 for
individual and combined group analyses. The best-fitted,
most-parsimonious genetic model was obtained as a com-
mon dominant allele (disease-allele frequencyp 0.2) with
low penetrances of 0.0005 for the susceptibility geno-
types. The estimated prevalence was 0.00018, which is
close to published reports (Hochberg 1997a; Lawrence et
al. 1998). The other genetic models were substantially in-
ferior to the most-parsimonious model (results not
shown). The model separately explained the inheritance
in the Hispanic families and EA-1 families surprisingly
well. The maximum LOD was virtually identical to the
HLOD for both the Hispanic and EA-1 ( ; i.e.,ap 1.0
100% of the families were linked to this locus under this
model). The peak linkage for both individual ethnic
groups, as well as for the combined groups, was at ap-
proximately the same position (fig. 2). We also analyzed
all 147 (EA-1 and AA) replication families together. The
LOD, HLOD, and a decreased to 1.05, 1.37, and 0.66,
respectively. This was certainly due to the genetic hetero-
geneity between the two ethnic groups.
Confirmation of Linkage at 12q24
Independent replication is typically viewed as the sine
qua non for acceptance of a hypothesis. Replicating an
established linkage applies the scientific method and a
gold standard too often not obtained in the linkage studies
of genetically complex phenotypes. Lander and Kruglyak
(1995) suggested a general guideline that the term “con-
firmation/replication study” should be reserved for those
situations in which significant evidence of linkage has al-
ready been obtained in an initial study. Accordingly, our
next goal was to confirm this linkage in an independent
data set by use of similar parametric and nonparametric
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Figure 2 Results of multipoint linkage analysis at 12q24 region for different groups. The Y-axis indicates the Zlr score, and the X-axis
indicates the chromosomal length spanned by three markers. The three markers and their intermarker distances (cM) are as follows: D12S2070-
13.9-D12S395-12.7-D12S2078.
analyses. Since we established elsewhere the SLE suscep-
tibility locus at this region (with genomewide signif-
icance), our a priori hypothesis of linkage was fixed at
12q24. In this situation, the multiple-testing problem as-
sociated with the genomewide search does not apply;
hence, to replicate the initial established linkage signal,
the significance of linkage would be set for P ! .05
(equivalent to and ), if no fineZ 1 1.64 LOD 1 0.59lr
mapping has been performed (Thomson 1994; Lander
and Kruglyak 1995; Ott 1999; Robert Elston, personal
communication).
For this purpose, we analyzed another independent
data set, which consisted of 82 EA families with SLE
(EA-2). On the basis of multipoint linkage analysis with
three genome scan markers, we detected the maximum
evidence of linkage on marker D12S395 in EA-2 by
nonparametric ( ; ) and parametricZ p 2.11 Pp .017lr
( , ; , ;LODp 0.86 Pp .023 HLODp 1.01 Pp .03
) analyses (fig. 2; table 4). On the basis of 10,000ap 0.73
simulations, the empirical P value for the observed Zlr
was 0.014, thereby individually replicating the linkage at
12q24.
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Table 3
Parameter Values for Five Different Plausible Genetic Models Used
in Parametric Linkage Analysis
GENETIC MODEL
DISEASE
ALLELE (A)
FREQUENCY
PENETRANCES
FOR GENOTYPES
AA Aa aa
High penetrant, rare recessive .02 .9 .0 .0
Low penetrant, common recessive .2 .008 .0 .0
High penetrant, rare dominant .0002 .9 .9 .0
Low penetrant, common dominant .2 .0005 .0005 .0
Low penetrant, rare additive .01 .04 .02 .0
Table 4
Results of Multipoint Parametric Model-Based (Most-Parsimonious
Model) Linkage Analysis
Population No. of Families LOD HLOD aa
Hispanic 37 1.87 1.87 1.00
EA-1 92 1.86 1.86 1.00
Hispanic  EA-1 129 3.72 3.72 1.00
EA-2 82 0.96 1.01 .73
EA-1  EA-2 174 2.78 2.80 .90
Hispanic  EA-1  EA-2 211 4.60 4.61 .95
NOTE.—Disease-allele frequency and the penetrances for the three
genotypes (AA, Aa, and aa, where A is the disease allele) were .2,
.0005, .0005, and .000, respectively.
a a p proportion of families linked.
Discussion
Genetic approaches now available to evaluate complex
diseases such as SLE offer great potential for establishing
linkage and then for identifying the disease gene(s). Pre-
vious SLE genome scans have proposed several candidate
regions for SLE susceptibility loci, some of which have
been independently confirmed upon replication. The link-
age at 12q24 now joins that group, which includes (along
with the associated candidate gene, when known) 1q23
(FcgRIIIA), 2q37 (PCDA-1), 4p15, 6p21 (HLA-DR), and
16q13 (Gaffney et al. 1998, 2000; Moser et al. 1998; Shai
et al. 1999; Gray-McGuire et al. 2000; Lindquivst et al.
2000; Edberg et al. 2002; Graham et al. 2002; Kelly et
al. 2002; Nath et al. 2002; Prokunina et al. 2002; Tsao
et al. 2002). These “confirmed” genetic effects are very
unlikely to be false positives, whereas validity of the vari-
ous other “unconfirmed” genetic linkages that have not
achieved this standard are less certain to be true SLE
susceptibility loci (Harley 2002; Kelly et al. 2002).
To identify novel susceptibility loci for SLE, we have
conducted a whole-genome scan in a group of Hispanic
families. Since parametric analyses are model dependent
and since misspecification of the disease model may lead
to a decrease in power (Clerget-Darpoux et al. 1986), we
used model-independent nonparametric analysis for the
initial genome scan. Our initial genome scan on Hispanic
families yielded two genomic regions (12q24 and 16q12-
21) with suggestive evidence ( ) of linkage andP  .001
a nearly suggestive ( ) evidence of linkage atPp .004
16p13. Following the method of Lander and Kruglyak
(1995), we pursued these linkages in extension studies,
in which data are combined in an effort to achieve sig-
nificant evidence for linkage. Assuming that common
susceptibility loci would influence the SLE phenotype
in other non-Hispanic populations, we used the AA and
EA families available to us for replication.
Significant decrease of linkage evidence at 12q24 was
found when we analyzed all 147 (92 EA-1 and 55 AA)
families with SLE in the replication data set. On the
other hand, a significantly increased linkage was present
in EA-1, thereby showing linkage heterogeneity at 12q24.
When we combined the Hispanic and EA-1 families, the
evidence of linkage exceeded the threshold for genome-
wide significance.
Once we established significant evidence of linkage at
12q24 by a nonparametric method, we sought a plausible
genetic transmission model by parametric linkage analy-
sis. With a complex disease such as SLE, none of these
simple models are likely to be exactly true, and the effect
of a gene and its variants can be reliably determined only
after the at-risk variant(s) has been identified. However,
the fitted parametric models approximate the contribu-
tion of this particular gene to the familial clustering of
the disease. Whereas the power to detect linkage by para-
metric LOD score analysis is sensitive to misspecification
of the genetic model, it has been shown that maximi-
zation of LOD scores over multiple genetic models in-
creases the power to detect linkage when the true mode
of inheritance of the disease is unknown (Hodge et al.
1997). We explored a range of plausible single-locus ge-
netic models (table 3). The most-parsimonious genetic
model was obtained as a low-penetrant, common, domi-
nant allele. As predicted elsewhere (Lander 1996; Chak-
ravarti 1999), the alleles at any single susceptibility gene
are more likely to have only small-to-moderate contri-
butions to the total risk of common complex phenotypes,
which has been demonstrated by our derived genetic
model obtained at 12q24.
Next, we evaluated linkage at 12q24 by another set
of 82 independently ascertained families with SLE
(EA-2). Replication of initial linkage signals from inde-
pendent samples is a crucial step toward distinguishing
between true positives and false positives (Lander and
Kruglyak 1995). However, replication of linkage results
for complex traits has been extremely difficult, owing
in part to the inability to precisely identify the under-
lying phenotype, small sample sizes and small multiplex
pedigrees, genetic heterogeneity, inaccurate genetic mod-
els, and the poor discriminating capacity of the statistical
methods employed in analysis (Suarez et al. 1994). More-
over, the considerable heterogeneity between data sets,
both within and between populations and ethnic groups,
must relatively impede efforts to confirm linkage. None-
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theless, we replicated the evidence for linkage at 12q24
by nonparametric, parametric, and simulation analyses.
We found that EA-2, unlike the Hispanic or EA-1 fami-
lies, displayed substantially greater heterogeneity (∼27%
of EA-2 families are not linked at 12q24).
It is interesting and important that Gaffney et al.
(2000) also reported the evidence of linkage at 12q24
in EA families. On the basis of study of the 65 EA fami-
lies, Gaffney et al. (2000) found evidence of linkage
( ; ; ) at 12q24. The peakZ p 2.24 LODp 1.09 Pp .01lr
they found was at 134.5 cM, whereas our peak is at
130.3 cM. This is not an unexpected shift for a complex
disease linkage. Therefore, on the basis of establishing
and confirming linkage in our independent data set and
a second confirmation in the published reports, this link-
age at 12q24 should be considered as definite evidence
of replication.
The linkage at 12q24 clearly appears to be race spe-
cific. The evidence for linkage primarily came from His-
panic and EA families. Virtually no evidence of linkage
was found in the AA families. The linkage evidence at
12q24 observed in family EA-2 was smaller than in
family EA-1. This can be explained by disease hetero-
geneity and ascertainment of the families. The disease
heterogeneity of SLE, similar to that of many other com-
plex genetics disorders, influences ascertainment; hence,
genetic effects are expected to be concentrated in any
given sample of the pedigrees on a random basis. Con-
sequently, pedigree contribution to the aggregate result
is expected to be smaller in the pedigrees used for rep-
lication. Suarez et al. (1994) demonstrated that if the
same criteria for significance are applied to localizing a
gene and to replicating its localization, approximately
five to six times as many families are required for rep-
lication as are required for an initial linkage finding.
Moreover, the estimated proportion of linkage hetero-
geneity in family EA-2 is high (∼27%). Simulation studies
predict that “nonreplications” of true linkages will be
common when small, heterogeneous samples are used to
detect genes of small effect. For example, 600–1,000 af-
fected sibling pairs would be required to reliably dem-
onstrate locus-specific genetic effects causing a 27%–
30% populationwide increase in risk to siblings (Hauser
et al. 1996); moreover, multiplicative gene effects are also
expected, which should be even more difficult to detect
(Rybicki and Elston 2000).
Our previous SLE genome scans identified two major
SLE susceptibility loci, 1q23 (Moser et al. 1998) and
4p16 (Gray-McGuire et al. 2000). It is interesting that
these evidences are not reproduced in the present study.
This may be due to two factors. First, the major linkage
effects identified from previous genome scans are mainly
based on AA (Moser et al. 1998) or EA (Gray-McGuire
et al. 2000) families. The present genome scan was done
on Hispanic families. Second, the sample size for His-
panics (37 families) may not be sufficient to detect these
loci identified elsewhere, especially for genetically hetero-
geneous disease (Suarez et al. 1994).
We found the maximum evidence of linkage (Pp
) at 66.8 cM in 16q12-21, between markers.001
D16S3253 and D16S2624, in the initial genome scan
of Hispanic families. Two earlier findings from Min-
nesota (Gaffney et al. 2000) and California (Shai et al.
1999), reported the SLE linkage at 16q13. Whereas the
Minnesota group found significant evidence (Pp
) for linkage at 67.2 cM on marker D16S41551.3# 10
(current Marshfield map) in EA families, the California
group found modest evidence ( ) for linkage toPp .017
marker D16S3136 at 62.1 cM in Mexican American
and EA families. According to the Lander and Kruglyak
(1995) criteria for replication and confirmation of a
previously established linkage, our results from the His-
panic families confirmed this linkage at 16q12. How-
ever, we could not replicate the evidence of linkage at
16q12-21 in our replication group. Presence of genetic
heterogeneity is considered to be the most likely expla-
nation. From our study, it has again become clear that,
in linkage studies of complex disorders, determining
whether a given study has replicated the findings of an
initial study is not a trivial task.
In this analysis, the purpose of dividing our family
collections into subsets was to increase genetic homo-
geneity of the families with respect to the specific pu-
tative susceptibility locus in which linkage can be es-
tablished and replicated. Selecting the Hispanic families
for this purpose involves a shared cultural experience,
implying environmental influences, perhaps, more than
a shared genetic population of origin among Hispanics.
In the United States, Hispanics are variably admixed with
populations originating in Europe, the Americas, and
Africa. Consequently, a genetic effect found in Hispanics
would be expected to be present in at least one of these
originating groups. Finding the 12q24 linkage in EAs
may fulfill this prediction.
Our current candidate interval spans a region of ∼15
Mb across chromosomal bands 12q24.1 (D12S2070) to
12q24.3 (D12S2078) and contains 120 known genes,
several partial transcripts, and several predicted tran-
scripts. Several biologically plausible candidate genes are
located within this chromosomal region. (The candidate-
gene locations were obtained from the April 2003 freeze
at the University of California–Santa Cruz “Golden
Path” Web site.) For example, NOS1 (nitric oxide syn-
thase 1), which showed association with asthma and re-
lated phenotypes (Grasemann 2001; Immervoll et al.
2001); TCF1 (transcription factor 1) associated with type
2 diabetes (Bulman et al. 2002); and IFN-g (interferon-
g) associated with asthma and atopy (Barnes et al. 1999)
are all located at 12q24. Linkage signals have also been
found in this region for other inflammatory diseases, in-
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cluding asthma (Yokouchi et al. 2002), diabetes (Mah-
tani et al. 1996; Ehm et al. 2000), and Graves disease
(Siegmund et al. 1998). Identification of the suscepti-
bility gene by the positional candidate cloning approach
will require study of many more families and further
narrowing of the candidate region.
In conclusion, our results provide strong evidence of
the existence of a major SLE susceptibility gene, SLEB4
on 12q24, that influences the SLE phenotypic variations,
especially in Hispanics and EAs. In addition, we con-
firmed the evidence of an already established SLE sus-
ceptibility locus located on chromosome 16q12-21. The
confirmation of these linkages at 12q24 and 16q12-21
to SLE strongly encourages efforts to identify the re-
sponsible susceptibility genes through positional cloning.
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